Gairing, S. J., Mildenberger, P., Gile, J., Artusa, F., Scheiner, B., Leyh, C., . . . Foerster, F. (2025). Evaluation of prognostic scores in patients with HCC undergoing first-line immunotherapy with atezolizumab and bevacizumab. Elsevier.
Chicago Style (17th ed.) CitationGairing, Simon Johannes, et al. Evaluation of Prognostic Scores in Patients with HCC Undergoing First-line Immunotherapy with Atezolizumab and Bevacizumab. Elsevier, 2025.
MLA引文Gairing, Simon Johannes, et al. Evaluation of Prognostic Scores in Patients with HCC Undergoing First-line Immunotherapy with Atezolizumab and Bevacizumab. Elsevier, 2025.
警告:這些引文格式不一定是100%准確.